The tryptophan-kynurenine-NAD+ (TK) pathway may provide accurate cerebrospinal fluid biomarkers.
Evidence of myocardial injury was found in roughly a quarter of patients with transient global amnesia.
A comprehensive profile of witness-observable transient loss of consciousness manifestations can make an important contribution to differentiation between epilepsy, syncope, and psychogenic nonepileptic seizures.
Researchers evaluated the incidence, course, and severity of neurodevelopmental impairments in survivors of cerebral malaria.
Researchers examined genetic and lifestyle risk factors for MRI-defined brain infarcts in 18 prospective population-based cohorts.
The FDA has accepted for Priority Review the supplemental Biologics License Application for Soliris for use in patients with neuromyelitis optica spectrum disorder.
Many systematic review protocols in the International Prospective Register of Systematic Reviews do not include adverse event reporting.
A dynamic pattern of coordinated and anticoordinated functional magnetic resonance imaging (fMRI) signals can characterize healthy individuals and minimally conscious patients.
The Food and Drug Administration (FDA) has granted Orphan Drug designation to APX001 for the treatment of cryptococcosis.
Over 1400 clinical trials and research studies were reviewed by a panel of 13 experts to develop the new guideline.